ScholarIQanswers from OpenAlex
Platelet Disorders and Treatments
TopicLeading institutions, researchers & key papers
Platelet Disorders and Treatments is a topic indexed in ScholarIQ from OpenAlex.
What is known about Platelet Disorders and Treatments?
ScholarIQrecord summary
This cluster of papers focuses on platelet disorders, thrombosis mechanisms, and related conditions such as immune thrombocytopenic purpura and von Willebrand disease. It covers topics including platelet function, hemostasis, inflammation, megakaryocyte development, and the molecular mechanisms underlying thrombus formation.
How many works does Platelet Disorders and Treatments have?
ScholarIQindexed works
Platelet Disorders and Treatments has 300 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Platelet Disorders and Treatments?
ScholarIQopenalex
The OpenAlex for Platelet Disorders and Treatments is on the source record.
What are the most-cited papers on Platelet Disorders and Treatments?
ScholarIQmost cited works
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert, Deirdra R. Terrell, Donald M. Arnold, George R. Buchanan, Douglas B. Cines, Nichola Cooper, Adam Cuker, Jenny M. Despotovic, James N. George, Rachael F. Grace, Thomas Kühne, David J. Kuter, Wendy Lim, Keith R. McCrae, Barbara Pruitt, Hayley Shimanek, Sara K. Vesely
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Éric Boilard, Peter A. Nigrović, Katherine Larabee, Gerald F. Watts, Jonathan S. Coblyn, Michael E. Weinblatt, Elena Massarotti, Eileen Remold‐O’Donnell, Richard W. Farndale, Jerry Ware, David Lee
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Yuqing Huo, Andreas Schober, S. Bradley Forlow, David F. Smith, Matthew C. Hyman, Steffen Jung, Dan R. Littman, Christian Weber, Klaus Ley
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
James B. Bussel, Donald M. Arnold, Elliot Grossbard, Jiřı́ Mayer, Jacek Treliński, Wojciech Homenda, Andrzej Hellmann, Jerzy Windyga, Liliya Sivcheva, Alhossain A. Khalafallah, Francesco Zaja, Nichola Cooper, Vadim Markovtsov, Hany Zayed, Anne‐Marie Duliège
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
Cindy Neunert, Nastaran Noroozi, Geoff Norman, George R. Buchanan, Jennifer Goy, Ishac Nazi, John G. Kelton, Donald M. Arnold
Where is Platelet Disorders and Treatments research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Platelet Disorders and Treatments is open access?
ScholarIQopen access share
47%OPEN ACCESS